These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 20841949)

  • 41. Bisphosphonate-associated osteonecrosis of the jaws.
    Goss AN
    Climacteric; 2007 Feb; 10(1):5-8. PubMed ID: 17364598
    [No Abstract]   [Full Text] [Related]  

  • 42. Intravenous bisphosphonate-associated osteonecrosis of the jaw.
    Statz TA; Guthmiller JM; Humbert LA; Johnson GK
    J Periodontol; 2007 Nov; 78(11):2203-8. PubMed ID: 17970689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].
    Ishikawa T
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):225-7. PubMed ID: 24743202
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preventive protocol for tooth extractions in patients treated with zoledronate: a case series.
    Ferlito S; Puzzo S; Liardo C
    J Oral Maxillofac Surg; 2011 Jun; 69(6):e1-4. PubMed ID: 21316136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Necrotizing fasciitis secondary to bisphosphonate-induced osteonecrosis of the jaw.
    Setabutr D; Hales NW; Krempl GA
    Am J Otolaryngol; 2010; 31(2):127-9. PubMed ID: 20015718
    [TBL] [Abstract][Full Text] [Related]  

  • 46. More on the resolution of bisphosphonate-associated osteonecrosis of the jaw.
    Tsai KY; Huang CS; Huang GM; Yu CT
    J Rheumatol; 2010 Mar; 37(3):675; author reply 676. PubMed ID: 20197569
    [No Abstract]   [Full Text] [Related]  

  • 47. Biophosphonate-related osteonecrosis of the jaws.
    Ruggiero SL; Woo SB
    Dent Clin North Am; 2008 Jan; 52(1):111-28, ix. PubMed ID: 18154867
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tetracycline-guided debridement and cone beam computed tomography for the treatment of bisphosphonate-related osteonecrosis of the jaw: a technical note.
    Fleisher KE; Doty S; Kottal S; Phelan J; Norman RG; Glickman RS
    J Oral Maxillofac Surg; 2008 Dec; 66(12):2646-53. PubMed ID: 19022151
    [No Abstract]   [Full Text] [Related]  

  • 49. Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw.
    Cicciù M; Herford AS; Juodžbalys G; Stoffella E
    J Craniofac Surg; 2012 May; 23(3):784-8. PubMed ID: 22565901
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bisphosphonate induced osteonecrosis of the jaw masquerading as tumor: a word of caution for oral surgeons and oncologists.
    Chaturvedi P; Pai PS; Chaukar DA; Gupta S; D'cruz AK
    Eur J Surg Oncol; 2010 Jun; 36(6):541-5. PubMed ID: 20071132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bisphosphonate related osteonecrosis of the jaw--manifestation in a microvascular iliac bone flap.
    Pautke C; Otto S; Reu S; Kolk A; Ehrenfeld M; Stürzenbaum S; Wolff KD
    Oral Oncol; 2011 May; 47(5):425-9. PubMed ID: 21478047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bisphosphonate-related osteonecrosis of the jaws an old disease with a new drug?
    Carlson ER
    Cranio; 2010 Jan; 28(1):1-2. PubMed ID: 20158003
    [No Abstract]   [Full Text] [Related]  

  • 53. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

  • 54. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw.
    Cella L; Oppici A; Arbasi M; Moretto M; Piepoli M; Vallisa D; Zangrandi A; Di Nunzio C; Cavanna L
    Head Face Med; 2011 Aug; 7():16. PubMed ID: 21849044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Osteonecrosis of the jaw and biphosphonates: imaging features].
    Orlandini F; Bossard D; Blanc G; Bodard AG; Gourmet R
    J Radiol; 2009 Feb; 90(2):199-205. PubMed ID: 19308004
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws.
    Chiandussi S; Biasotto M; Dore F; Cavalli F; Cova MA; Di Lenarda R
    Dentomaxillofac Radiol; 2006 Jul; 35(4):236-43. PubMed ID: 16798918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Osteomyelitis of the jaw in breast cancer patients receiving bisphosphonate therapy].
    Tomihara K; Nagai I; Yamaguchi A; Miyazaki A; Dehari H; Abe M; Nakamori K; Komai K; Nakai M; Hiratsuka H
    Gan To Kagaku Ryoho; 2008 Jan; 35(1):113-6. PubMed ID: 18195538
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series.
    Fedele S; Porter SR; D'Aiuto F; Aljohani S; Vescovi P; Manfredi M; Arduino PG; Broccoletti R; Musciotto A; Di Fede O; Lazarovici TS; Campisi G; Yarom N
    Am J Med; 2010 Nov; 123(11):1060-4. PubMed ID: 20851366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
    Delibasi T; Altundag K; Kanlioglu Y
    J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.